Key Points • Low prelymphodepletion mHLA-DR correlates with older age, poorer ECOG performance status, higher tumor burden, and systemic inflammation.• Low prelymphodepletion mHLA-DR is associated with poorer duration of response… Click to show full abstract
Key Points • Low prelymphodepletion mHLA-DR correlates with older age, poorer ECOG performance status, higher tumor burden, and systemic inflammation.• Low prelymphodepletion mHLA-DR is associated with poorer duration of response and survival in LBCL treated with anti-CD19 CAR T cells.
               
Click one of the above tabs to view related content.